{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:14:52Z","timestamp":1786990492599,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijcard.2016.09.014","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T04:44:10Z","timestamp":1474001050000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A low plasma 1,25(OH) 2 vitamin D\/PTH (1\u201384) ratio predicts worsening of renal function in patients with chronic heart failure"],"prefix":"10.1016","volume":"224","author":[{"given":"Serge","family":"Masson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Barlera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Colotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Magnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marchioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Tognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.09.014_bb0005","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/eurheartj\/ehs205","article-title":"The role of the kidney in heart failure","volume":"33","author":"Metra","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0010","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ejhf.210","article-title":"Impact of worsening renal function related to medication in heart failure","volume":"17","author":"Brunner-La Rocca","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jchf.2014.11.004","article-title":"Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure","volume":"3","author":"Kiernan","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijcard.2014.04.162","article-title":"Worsening renal function in heart failure: the need for a consensus definition","volume":"174","author":"Sheerin","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000346789","article-title":"Vitamin D in chronic kidney disease","volume":"180","author":"Li","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00774-010-0192-1","article-title":"Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages","volume":"29","author":"Patel","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"Schierbeck","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135427","article-title":"1,25-dihydroxyvitamin D to PTH(1\u201384) ratios strongly predict cardiovascular death in heart failure","volume":"10","author":"Gruson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejheart.2004.03.001","article-title":"Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure","volume":"6","author":"Tavazzi","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0070","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0075","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Investigators","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0080","article-title":"A novel, fully-automated, chemiluminescent assay for the detection of 1,25-dihydroxyvitamin D in biological samples","author":"Valcour","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-15-0595","article-title":"Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients","volume":"174","author":"Souberbielle","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0090","series-title":"Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0095","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/eurjhf\/hft089","article-title":"Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study","volume":"15","author":"Lesogor","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0105","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jacc.2014.01.087","article-title":"Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment","volume":"64","author":"Damman","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","article-title":"Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation","volume":"62","author":"Block","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2014.12.016","article-title":"Cardiorenal syndrome and the role of the bone-mineral axis and anemia","volume":"66","author":"Charytan","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","article-title":"Vitamin D therapy in chronic kidney disease and end stage renal disease","volume":"7","author":"Melamed","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000355747","article-title":"New insights on the role of vitamin D in the progression of renal damage","volume":"37","author":"Lucisano","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ejcn.2009.140","article-title":"Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"64","author":"Semba","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/joim.12232","article-title":"The fibroblast growth factor-23 and vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk","volume":"277","author":"Masson","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065785","article-title":"Vitamin D (25OHD) serum seasonality in the United States","volume":"8","author":"Kasahara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.09.014_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCHEARTFAILURE.112.967828","article-title":"Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram","volume":"6","author":"Barlera","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/eurjhf\/hfq112","article-title":"The vitamin D system: a crosstalk between the heart and kidney","volume":"12","author":"Cozzolino","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.17987\/icfj.v1i5.60","article-title":"Cardiovascular calcification and bone: a comparison of the effects of dietary and serum calcium, phosphorous, magnesium and vitamin D","volume":"1","author":"Nicoll","year":"2014","journal-title":"Int. Cardiovasc. Forum J."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0160","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/eurjhf\/hfr032","article-title":"Vitamin D status and outcomes in heart failure patients","volume":"13","author":"Liu","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","article-title":"Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome","volume":"14","author":"Gotsman","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.09.014_bb0170","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1373\/clinchem.2015.244913","article-title":"Effect of vitamin D or activated vitamin D on circulating 1,25-dihydroxyvitamin D concentrations: a systematic review and metaanalysis of randomized controlled trials","volume":"61","author":"Zittermann","year":"2015","journal-title":"Clin. Chem."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316321556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316321556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T07:26:19Z","timestamp":1536391579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316321556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"alternative-id":["S0167527316321556"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.014","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A low plasma 1,25(OH)2 vitamin D\/PTH (1\u201384) ratio predicts worsening of renal function in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}